Ken Williams

15 papers receiving 5.5k citations

Ken Williams's Hit Papers

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus 2002 · 768 citations
7680+9+18Years since publication10002.0k3.0k4.0k

Peers

Ken Williams
Comparison fields: 5 of 118
  • Endocrinology, Diabetes and Metabolism 2.3k
  • Cardiology and Cardiovascular Medicine 1.7k
  • Ophthalmology 512
  • Nephrology 367
  • Pharmacology 370
Replace Rob Newton with:
Rob Newton United Kingdom
Peter S. Griffin United States
Joelle Singer Israel
Craig A. Munroe United States
J Wain United Kingdom
Carole Merle France
Samantha L. Clarke Australia
F. Johnson United States
M. Charlton United Kingdom
Philip Musk United States
Ken Williams relative to Rob Newton United Kingdom Rob Newton's profile →
Citations per field
00.5×1.5×
Rob Newton · 1×
Citations per year

Countries citing papers authored by Ken Williams

Since Specialization
Citations

This map shows the geographic impact of Ken Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Williams more than expected).

Fields of papers citing papers by Ken Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Williams. The network helps show where Ken Williams may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Williams Line = papers co-authored together Ken Williams links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Hit paper breakdown →
19984201
2
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
Hit paper breakdown →
2002768
3 2006221
4 2002164
5 2006119
6 2004115
7 2008106
8 201452
9 200742
10 201640
11 200514
12 200312
13 200910
14 20189
15 20054

About Ken Williams

Ken Williams is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Bioengineering, Emergency Medical Services and Nephrology, having authored 15 papers that have together received 5.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Diabetes and associated disorders (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Pancreatic function and diabetes (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Primary Care and Health Outcomes (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Cardiology and Cardiovascular Medicine (1.7k citations), Ophthalmology (512 citations), Nephrology (367 citations) and Pharmacology (370 citations). Ken Williams has collaborated with scholars based in United States, Mexico and United Kingdom. Frequent co-authors include Steven M. Haffner, Wayde M. Weston, Andrew S. Greenberg, Martin I. Freed, Hongzi Chen, Andreas Festa, Lynne E. Wagenknecht, Ralph B. D’Agostino, Naveed A. Sattar and Anthony J. Hanley. Their work appears in journals such as Diabetes, Circulation, Australian and New Zealand Journal of Public Health, Journal of Breath Research and Archives of Medical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact